Adverse Events in Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Adverse Events in Clinical Trials in Mexico

Adverse Events in Clinical Trials in Mexico – Clinical Research in LATAM

Clinical trials are an essential component of medical research, providing valuable insights into the safety and efficacy of new treatments and medications. These trials are conducted to evaluate the potential benefits and risks of experimental drugs before they can be approved for widespread use.

One critical aspect of clinical trials is monitoring and reporting adverse events (AEs), which are undesirable or harmful effects experienced by participants during the study. In Mexico, as in any country, safeguarding patient safety during clinical trials is of utmost importance. This blog delves into the significance of adverse event reporting in Mexico and the measures taken to ensure the ethical conduct of clinical research.

The Importance of Clinical Trials in Mexico

Clinical trials play a crucial role in advancing medical knowledge and improving healthcare outcomes for patients in Mexico. By participating in clinical trials, patients have the opportunity to access potentially groundbreaking treatments not yet available to the general public. Additionally, these trials contribute to the development of novel therapies that can address unmet medical needs and improve the overall health of the population.

Ensuring Ethical Conduct in Clinical Trials

To protect the rights and safety of participants, clinical trials in Mexico are regulated by the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) and the General Health Council.

These regulatory bodies oversee the ethical conduct of clinical research and require adherence to internationally recognized guidelines, such as the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines established by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

The Role of Adverse Event Reporting

Adverse event reporting is a critical aspect of clinical trials that focuses on identifying, documenting, and managing any unexpected or undesirable effects experienced by study participants. This process is essential in comprehensively assessing the safety profile of an investigational drug. When adverse events occur, researchers are obligated to take appropriate actions to protect participants and maintain the integrity of the trial.

Challenges in Adverse Event Reporting

Despite the robust regulations in place, the reporting of adverse events in clinical trials can present challenges. Some common challenges include underreporting by healthcare professionals, inadequate communication between stakeholders, and delayed reporting due to a lack of awareness or understanding of the reporting process.

These challenges can undermine the accurate assessment of a drug’s safety profile, potentially compromising patient safety and the overall validity of the trial results.

Adverse Events in Clinical Trials in Mexico

Adverse Events in Clinical Trials in Mexico

Adverse Events in Clinical Trials in Mexico

Addressing Challenges and Enhancing Patient Safety

To overcome the challenges associated with adverse event reporting, various strategies are implemented in Mexico. These include:

  1. Training and Education: Healthcare professionals involved in clinical trials receive training on adverse event reporting, emphasizing the importance of timely and accurate documentation. Additionally, patient education ensures that participants are aware of potential risks and how to report any adverse events they may experience.
  2. Transparent Communication: Effective communication among all stakeholders, including researchers, sponsors, and regulatory authorities, is essential to ensure that adverse events are promptly communicated and appropriately addressed.
  3. Data Monitoring Committees (DMCs): Independent DMCs are established to regularly review trial data, including adverse events, to ensure participant safety and make informed decisions regarding trial continuation or modifications.
  4. Pharmacovigilance Systems: Robust pharmacovigilance systems are set up to continually monitor the safety of approved drugs, allowing for the timely identification and reporting of adverse events post-approval.
  5. Collaboration and International Standards: Mexico collaborates with international organizations and regulatory agencies to align its standards with global best practices, enhancing the credibility of its clinical research and promoting patient safety.


Adverse event reporting in clinical trials is a crucial process that safeguards the well-being of study participants and ensures the integrity of research outcomes. In Mexico, regulatory authorities and researchers work together to ensure that clinical trials are conducted ethically, adhering to rigorous standards and guidelines.

By fostering transparent communication, promoting education, and addressing challenges, Mexico continues to contribute significantly to the advancement of medical knowledge and the improvement of healthcare outcomes through responsible and safe clinical research.

In the pursuit of better healthcare, the dedication to ethical clinical research remains a cornerstone in Mexico’s journey towards improving the well-being of its people and contributing to global medical advancements.

Adverse Events in Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Adverse Events in Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Adverse Events in Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Adverse Events in Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Adverse Events in Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Adverse Events in Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Adverse Events in Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Adverse Events in Clinical Trials in Mexico

The Cohortias Team

Adverse Events in Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Adverse Events in Clinical Trials in Mexico

Network & Partnerships